Natural Biocon Intrinsic Value
Natural Biocon (NATURAL) median intrinsic value is ₹8.70 from 2 valuation models (range ₹1–₹9), vs current price ₹3.48 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. Also explore NATURAL price trends to track price trends across different timeframes.
NATURAL Valuation Methods Summary — DCF, Graham Number & P/E
Natural Biocon intrinsic value across 2 models vs current price ₹3.48 — upside/downside and value range per method. Browse Natural Biocon annual reports for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹8.70 | ₹7.83 - ₹9.57 | +150.0% | Book Value/Share: ₹11.92, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1.04 | ₹0.94 - ₹1.14 | -70.1% | Revenue/Share: ₹1.15, P/S: 0.8x |
NATURAL Intrinsic Value vs Market Price — All Valuation Models
Natural Biocon fair value range ₹1–₹9 vs current market price ₹3.48 across 2 valuation models. For current market price and key ratios, visit NATURAL screener.
NATURAL Intrinsic Value Analysis — Undervalued or Overvalued?
Natural Biocon median intrinsic value ₹8.70, current price ₹3.48 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.
What is the intrinsic value of NATURAL?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Natural Biocon (NATURAL) is ₹8.70 (median value). With the current market price of ₹3.48, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹1.04 to ₹8.70, indicating ₹1.04 - ₹8.70.
Is NATURAL undervalued or overvalued?
Based on our multi-method analysis, Natural Biocon (NATURAL) appears to be trading below calculated value by approximately 150.0%.
NATURAL Financial Health — Key Ratios vs Industry Benchmarks
Natural Biocon financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Operating Margin | -1.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.08x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
NATURAL Cash Flow Quality — Operating & Free Cash Flow
Natural Biocon operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹1 Cr | ₹-10 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |